Home | Welcome to Contract Pharma   
Last Updated Tuesday, July 22 2014
Print RSS Feed

Breaking News

Related Searches:
August 13, 2010
Trubion Pharmaceuticals, Inc. has signed an agreement to be acquired by Emergent BioSolutions, Inc. for approximately $96.8 million.  Read More »
August 13, 2010
Quay Pharma has been selected by a leading Japanese pharmaceutical company to provide clinical trial drug manufacture of two NCEs.   Read More »
August 13, 2010
Naren Mallakunta has been named chief executive officer of Laxai Pharma, Ltd., joining the company's management team.   Read More »
August 12, 2010
Carlos Martínez Manchado has joined the Analytical Chemistry department at Ricerca Biosciences.   Read More »
August 12, 2010
Genzyme Corp. expects changes requested by the FDA after a contamination at its Allston plant to take as many as four years longer than previously projected.  Read More »
August 12, 2010
CLC bio and PSSC Labs introduced a new solution, CLC Genomics Factory, for assembly, read mapping, and subsequent downstream analysis of very large amounts of high-throughput DNA and RNA sequencing data.  Read More »
August 12, 2010
NextWave Pharmaceuticals and Tris Pharma have entered a collaboration agreement under which Tris Pharma will use its drug delivery technology for liquid and solid formulations to enhance NextWave's CNS product portfolio.  Read More »
August 12, 2010
Edward Hu has been appointed chief financial officer of WuXi PharmaTech, effective immediately.   Read More »
August 11, 2010
Merck Sharp & Dohme Co. has reacquired the Cherokee Pharmaceutical plant that was previously sold to PRWT Services, Inc. more than two years ago. Details of the transaction were not disclosed.  Read More »
August 11, 2010
Sanofi-Aventis has selected SCM Pharma for the fast-tracked fill/finish of a radio-labelled product.   Read More »
August 11, 2010
Xcelience has expanded its formulation development and manufacturing capabilities with the addition of a Piccola B10 Minipress.   Read More »
August 10, 2010
Sanofi-Aventis and Scripps Genomic Medicine (SGM) entered a strategic alliance to advance R&D initiatives in the field of personalized medicine.  Read More »
August 10, 2010
Scancell Holdings and Cancer Research Technology, Ltd. (CRT) have signed an agreement under which Scancell has been granted a license to use a human antibody known as 105AD7.  Read More »
August 10, 2010
Clinical Research Services revenue in the quarter was $225.4 million (+11%).  Read More »
August 10, 2010
Elan Corp. and Transition Therapeutics, Inc reported results from a Phase II study of ELND005 (Scyllo-inositol) in patients with mild to moderate Alzheimer’s disease.  Read More »

Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On